USE OF RITONAVIR (ABT-538) TO IMPROVE THE PHARMACOKINETICS OF MEDICAMENTS METABOLIZED BY CYTOCHROM P450 IN THE CONTEXT OF THE TREATMENT OF AIDS

摘要

There is described a combination of ritonavir or a pharmaceutically acceptable salt thereof in combination with another HIV protease inhibitor, formulated as a single or separate composition, for use in the inhibition or treatment of an HIV infection or AIDS in a human host.